News

Surgery adds little after successful chemo in metastatic breast cancer


 

SAN ANTONIO – In patients with metastatic breast cancer who responded favorably to initial chemotherapy, radiotherapy and surgical removal of primary tumors failed to enhance overall survival, a new study has shown.

In an interview at the San Antonio Breast Cancer Symposium, study investigator Dr. Rajendra Badwe offers his perspectives on loco-regional treatment vs. chemotherapy alone, and he discusses why surgical removal of primary tumors might be linked to later spread of metastatic disease.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

Recommended Reading

Breast MRI both overused and underused
Breast Cancer ICYMI
Genetic profiling transforms cancer treatment trials
Breast Cancer ICYMI
Walking program eased chemo-related joint pain
Breast Cancer ICYMI
Canadian agency reports rare, severe skin reactions to cancer drug
Breast Cancer ICYMI
Pathologic complete response to HER2 therapy portends better outcomes
Breast Cancer ICYMI
Radiotherapy can be omitted for many older breast cancer patients
Breast Cancer ICYMI
VIDEO: Tumor-infiltrating lymphocytes may predict trastuzumab success
Breast Cancer ICYMI
Dasatinib gives letrozole a boost in HR-positive advanced breast cancer
Breast Cancer ICYMI
IBIS-II: Anastrozole highly effective in preventing breast cancer
Breast Cancer ICYMI
No gain seen from adjuvant bevacizumab in HER2-positive disease
Breast Cancer ICYMI